Author Archives: Guest Blogger

Could Pharma Do Tumblr?

By Guest Blogger | Published: May 22, 2013
Could acquisition by Yahoo make Tumblr more interesting to Pharma? I’m sure you’ve heard already – Internet geriatric Yahoo just bought six-year old Tumblr for $1.1 billion. The deal, likely to complete in the second half of this year, is almost all cash – reportedly almost all the cash Yahoo had in hand at the close [...]
Posted in Guest Blog, Op-Ed, Technology, social media | Tagged , , , | 2 Comments

Your 2014 Medicaid Sales & Marketing Plans

By Guest Blogger | Published: May 21, 2013
by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you:  How exactly are you planning your 2014 Medicaid strategy?
Posted in Advertising, Guest Blog, Legal, Market Access, Marketing, Regulatory, Sales, Strategy, healthcare, pricing | Tagged , , , , , , , , , , | Leave a comment

Protecting Your "Online Reputation"

By Guest Blogger | Published: May 21, 2013
By Don Sorenson. For CEOs who have spent long years and countless funds building a solid pharmaceutical brand and life-changing drugs, discovering defamatory remarks about your company online can come as quite a shock. Even worse, the negative comments about the company are often published on social media and popular review websites that rank high in [...]
Posted in Guest Blog, Marketing, social media | Tagged , , , , , | 1 Comment

The UK's New "Revolutionary" Medicines Optimization Plan

By Guest Blogger | Published: May 21, 2013
By Leela Barham. The UK’s Royal Pharmaceutical Society has joined forces with a number of other organizations, including the Association of the British Pharmaceutical Industry (ABPI), to issue new guidance on medicines optimization.  Sir Bruce Keogh, Medical Director of NHS England, says it could be revolutionary.
Posted in Europe, Global, Guest Blog, Op-Ed | Tagged , , , , , , | Leave a comment

Global Biosimilars Market to Reach $2.4 Billion in 2013

By Guest Blogger | Published: May 17, 2013
By Adeline Siew, Editor, Pharmaceutical Technology Europe. The global market for biosimilar drugs has been forecasted to be worth $2.445 billion this year, according to a new report by British market research specialist Visiongain. The growth represents a 20% increase from last year and accounts for approximately 2% of the overall biologics market. Moreover, the global [...]
Posted in Biotech, Global, Guest Blog, R&D | Tagged , , , | Leave a comment